title: Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
abstract: OBJECTIVE
  Because of their capacity to modulate the immune response and promote tissue repair, mesenchymal stromal cells (MSC) represent a potential novel treatment for autoimmune/inflammatory diseases, including Crohn's disease (CD). The aim of the study was in vitro characterization of MSC from active CD patients for future clinical application.
  
  
  METHODS
  MSC from the bone marrow (BM) of seven CD patients (median age 32 years) were expanded ex vivo in the presence of 5% platelet lysate; cells were investigated for clonogenic efficiency, proliferative capacity, morphology, immunophenotype, differentiation potential, genetic stability and ability to suppress in vitro proliferation of both autologous and allogeneic lymphocytes to polyclonal mitogens. Results were compared with those of BM MSC of four healthy donors (HD).
  
  
  RESULTS
  MSC were successfully expanded from all patients. Colony-forming unit-fibroblast (CFU-F) frequency and proliferative capacity were comparable in CD and HD MSC. CD MSC showed typical spindle-shaped morphology and differentiated into osteoblasts, adipocytes and chondrocytes. Surface immunologic markers did not differ between CD and HD MSC, with the only exception of sizeable levels of HLA-DR at early culture passages [12-84% at passage (P)1] in the former. CD MSC ceased their growth at variable passages (from P8 to P25) and entered senescence without any change in morphology/proliferation rate. Array-comparative genomic hybridization demonstrated that CD MSC do not show imbalanced chromosomal rearrangements. Both CD and HD MSC inhibited in vitro proliferation of lymphocytes to mitogens.
  
  
  CONCLUSIONS
  CD MSC show biologic characteristics similar to HD MSC and can be considered for anti-inflammatory and reparative cell therapy approaches in patients with refractory disease.
authors.affiliation: Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy. mebernardo@gmail.com
authors.forename: Maria Ester
authors.initials: ME
authors.lastname: Bernardo
authors.forename: Maria Antonia
authors.initials: MA
authors.lastname: Avanzini
authors.forename: Rachele
authors.initials: R
authors.lastname: Ciccocioppo
authors.forename: Cesare
authors.initials: C
authors.lastname: Perotti
authors.forename: Angela Maria
authors.initials: AM
authors.lastname: Cometa
authors.forename: Antonia
authors.initials: A
authors.lastname: Moretta
authors.forename: Massimo
authors.initials: M
authors.lastname: Marconi
authors.forename: Monica
authors.initials: M
authors.lastname: Valli
authors.forename: Francesca
authors.initials: F
authors.lastname: Novara
authors.forename: Federico
authors.initials: F
authors.lastname: Bonetti
authors.forename: Orsetta
authors.initials: O
authors.lastname: Zuffardi
authors.forename: Rita
authors.initials: R
authors.lastname: Maccario
authors.forename: Gino Roberto
authors.initials: GR
authors.lastname: Corazza
authors.forename: Franco
authors.initials: F
authors.lastname: Locatelli
mesh_terms: D000293:Adolescent; D000328:Adult; D001853:Bone Marrow / Q000473:pathology; D002454:Cell Differentiation; D049109:Cell Proliferation; D003424:Crohn Disease / Q000628:therapy*; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D039902:Multipotent Stem Cells / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D013234:Stem Cells